Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.
Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, Hattangadi-Gluth JA, Seibert TM, Srikant A, Jones KA, Snyder VS, Dale AM, White NS, McDonald CR, Farid N. Delfanti RL, et al. Among authors: piccioni de. J Neurooncol. 2017 Dec;135(3):601-609. doi: 10.1007/s11060-017-2613-7. Epub 2017 Sep 4. J Neurooncol. 2017. PMID: 28871469 Free PMC article.
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment.
Bota DA, Taylor TH, Piccioni DE, Duma CM, LaRocca RV, Kesari S, Carrillo JA, Abedi M, Aiken RD, Hsu FPK, Kong XT, Hsieh C, Bota PG, Nistor GI, Keirstead HS, Dillman RO. Bota DA, et al. Among authors: piccioni de. J Exp Clin Cancer Res. 2022 Dec 14;41(1):344. doi: 10.1186/s13046-022-02552-6. J Exp Clin Cancer Res. 2022. PMID: 36517865 Free PMC article. Clinical Trial.
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.
Piccioni DE, Selfridge J, Mody RR, Chowdhury R, Li S, Lalezari S, Wawrzynski J, Quan J, Zurayk M, Chou AP, Sanchez DE, Liau LM, Ellingson BM, Pope WB, Nghiemphu PL, Green RM, Wang HJ, Yong WH, Elashoff R, Cloughesy TF, Lai A. Piccioni DE, et al. Neuro Oncol. 2014 Jun;16(6):815-22. doi: 10.1093/neuonc/nou028. Epub 2014 Mar 13. Neuro Oncol. 2014. PMID: 24627236 Free PMC article.
Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.
McDonald CR, Delfanti RL, Krishnan AP, Leyden KM, Hattangadi-Gluth JA, Seibert TM, Karunamuni R, Elbe P, Kuperman JM, Bartsch H, Piccioni DE, White NS, Dale AM, Farid N. McDonald CR, et al. Among authors: piccioni de. Neuro Oncol. 2016 Nov;18(11):1579-1590. doi: 10.1093/neuonc/now063. Epub 2016 Apr 21. Neuro Oncol. 2016. PMID: 27106406 Free PMC article.
Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma.
Krishnan AP, Karunamuni R, Leyden KM, Seibert TM, Delfanti RL, Kuperman JM, Bartsch H, Elbe P, Srikant A, Dale AM, Kesari S, Piccioni DE, Hattangadi-Gluth JA, Farid N, McDonald CR, White NS. Krishnan AP, et al. Among authors: piccioni de. AJNR Am J Neuroradiol. 2017 May;38(5):882-889. doi: 10.3174/ajnr.A5099. Epub 2017 Mar 9. AJNR Am J Neuroradiol. 2017. PMID: 28279985 Free PMC article.
Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.
Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, Hattangadi-Gluth JA, Seibert TM, Srikant A, Jones KA, Snyder VS, Dale AM, White NS, McDonald CR, Farid N. Delfanti RL, et al. Among authors: piccioni de. J Neurooncol. 2017 Dec;135(3):611. doi: 10.1007/s11060-017-2620-8. J Neurooncol. 2017. PMID: 28905256
73 results